Daniel Wilson to Risk Factors
This is a "connection" page, showing publications Daniel Wilson has written about Risk Factors.
Connection Strength
0.049
-
Hyperkalemia Risk with Finerenone: Results from the FIDELIO-DKD Trial. J Am Soc Nephrol. 2022 01; 33(1):225-237.
Score: 0.023
-
Relation Between Change in Renal Function and Cardiovascular Outcomes in Atorvastatin-Treated Patients (from the Treating to New Targets [TNT] Study). Am J Cardiol. 2016 Apr 15; 117(8):1199-205.
Score: 0.015
-
Molecular and spatial epidemiology of human campylobacteriosis: source association and genotype-related risk factors. Epidemiol Infect. 2010 Oct; 138(10):1372-83.
Score: 0.010